C. Mondino National Neurological Institute Foundation, IRCCS, Pavia, Italy.
MRC Centre for Neuromuscular Diseases, UCL Institute of Neurology, London, UK.
Eur J Neurol. 2018 Jan;25(1):154-163. doi: 10.1111/ene.13478. Epub 2017 Dec 2.
Mutations in the small heat-shock protein 22 gene (HSPB8) have been associated with Charcot-Marie-Tooth disease type 2L, distal hereditary motor neuropathy (dHMN) type IIa and, more recently, distal myopathy/myofibrillar myopathy (MFM) with protein aggregates and TDP-43 inclusions. The aim was to report a novel family with HSPB8 -related dHMN/MFM and to investigate, in a patient muscle biopsy, whether the presence of protein aggregates was paralleled by altered TDP-43 function.
We reviewed clinical and genetic data. We assessed TDP-43 expression by qPCR and alternative splicing of four previously validated direct TDP-43 target exons in four genes by reverse transcriptase-polymerase chain reaction.
The triplets and their mother presented in the second to third decade of life with progressive weakness affecting distal and proximal lower limb and truncal muscles. Nerve conduction study showed a motor axonal neuropathy. The clinical features, moderately raised creatin kinase levels, selective pattern of muscle involvement on magnetic resonance imaging and pathological changes on muscle biopsy, including the presence of protein aggregates, supported the diagnosis of a contemporary primary muscle involvement. In affected muscle tissue we observed a consistent alteration of TDP-43-dependent splicing in three out of four TDP-43-target transcripts (POLDIP3, FNIP1 and BRD8), as well as a significant decrease of TDP-43 mRNA levels.
Our study confirmed the role of mutated HSPB8 as a cause of a combined neuromuscular disorder encompassing dHMN and MFM with protein aggregates. We identified impaired RNA metabolism, secondary to TDP-43 loss of function, as a possible pathological mechanism of HSPB8 toxicity, leading to muscle and nerve degeneration.
小热休克蛋白 22 基因(HSPB8)的突变与 Charcot-Marie-Tooth 病 2L 型、远端遗传性运动神经病(dHMN)Ⅱa 型以及最近的伴有蛋白聚集物和 TDP-43 包涵体的远端肌病/肌原纤维肌病(MFM)有关。本研究旨在报道一个 HSPB8 相关的 dHMN/MFM 的新家族,并在患者的肌肉活检中研究蛋白聚集物的存在是否伴随着 TDP-43 功能的改变。
我们回顾了临床和遗传学数据。我们通过 qPCR 评估 TDP-43 的表达,并通过逆转录-聚合酶链反应(RT-PCR)评估四个先前验证的直接 TDP-43 靶外显子在四个基因中的选择性剪接。
患者的三胞胎及其母亲在第二至第三个十年期间出现进行性无力,影响下肢和躯干的远端和近端肌肉。神经传导研究显示运动轴索性神经病。临床特征、肌酸激酶水平中度升高、磁共振成像上肌肉受累的选择性模式以及肌肉活检的病理学变化,包括蛋白聚集物的存在,支持原发性肌肉受累的当代诊断。在受累的肌肉组织中,我们观察到四个 TDP-43 靶转录物(POLDIP3、FNIP1 和 BRD8)中的三个的 TDP-43 依赖性剪接发生一致改变,以及 TDP-43 mRNA 水平显著降低。
我们的研究证实了突变 HSPB8 作为一种引起包含蛋白聚集物的 dHMN 和 MFM 的神经肌肉疾病的原因。我们发现,TDP-43 功能丧失导致 RNA 代谢受损,可能是 HSPB8 毒性的病理机制之一,导致肌肉和神经变性。